Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Brain : a Journal of Neurology|December 13, 2002
Lead neurotoxicity in children: basic mechanisms and clinical correlatesTheodore I Lidsky, Jay S SchneiderJournal of Occupational and Environmental Medicine|May 9, 2014
Is the Aluminum Hypothesis dead?Theodore I LidskyEuropean Journal of Pharmacology|May 7, 2008
Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in ratsMervan S Agovic, Elena Yablonsky-Alter, Theodore I Lidsky, et al.Environmental Health Perspectives|August 28, 2023
Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?Jay S SchneiderPlos One|June 15, 2018
Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's diseaseJay S SchneiderInternational Journal of Molecular Sciences|June 10, 2023
GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic MechanismsJay S SchneiderThe Journal of Pharmacology and Experimental Therapeutics|September 24, 2004
Clozapine protection against gestational cocaine-induced neurochemical abnormalitiesElena Yablonsky-Alter, Eleonora Gashi, Theodore I Lidsky, et al.Molecular and Cellular Neurosciences|January 7, 2019
siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegenerationMegha Verma, Jay S SchneiderNPJ Parkinson'S Disease|June 8, 2026
Sleep-circadian modulation of autophagy and glymphatic function: failure of coordinated brain clearance in Parkinson's diseaseShamaila Zafar, Jay S SchneiderNeuropharmacology|November 14, 2021
Current concepts in treating mild cognitive impairment in Parkinson's diseaseJay S Schneider, Sandhya KortagerePageof 7